Compare FOSL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOSL | RPID |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.1M | 204.3M |
| IPO Year | 1993 | 2021 |
| Metric | FOSL | RPID |
|---|---|---|
| Price | $3.82 | $3.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 625.6K | 340.8K |
| Earning Date | 03-11-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,066,179,000.00 | $30,523,000.00 |
| Revenue This Year | N/A | $19.91 |
| Revenue Next Year | N/A | $21.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.63 |
| 52 Week Low | $0.86 | $1.86 |
| 52 Week High | $4.49 | $4.94 |
| Indicator | FOSL | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 47.86 |
| Support Level | $3.24 | $3.66 |
| Resistance Level | $3.82 | $4.40 |
| Average True Range (ATR) | 0.34 | 0.40 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 42.80 | 11.72 |
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.